RETRACTED: Prophylactic antiemetic efficacy of granisetron in patients with and without previous postoperative emesis (Retracted article. See vol. 59, pg. 1167, 2012)

被引:11
作者
Fujii, Y [1 ]
Tanaka, H [1 ]
Toyooka, H [1 ]
机构
[1] TORIDE KYODO GEN HOSP, DEPT ANAESTHESIOL, TORIDE, IBARAKI, JAPAN
来源
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE | 1997年 / 44卷 / 03期
关键词
D O I
10.1007/BF03015365
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Purpose: To evaluate the efficacy of granisetron, a selective antagonist of 5-hydroxytryptamine type 3 receptors, in the prevention of PONV in patients with and without previous postoperative emesis undergoing general anaesthesia for major gynaecological surgery. Methods: In a randomized, double-blind, placebo-controlled trial of 90 women with (n=40) and without (n=50) a history of PONV, the patients received either granisetron (40 mu g . kg(-1) or placebo (saline) iv immediately; before induction of anaesthesia, The same standard general anaesthetic technique, which consisted of isoflurane. in nitrous oxide and oxygen and avoided opioids, was used, Nausea, vomiting and safety assessments were per formed during the first 24 hr after anaesthesia, Results: The incidence of PONV was 70% and 25% after administration of placebo and granisetron in patients with previous PONV (P<0.05), and was 40% and 8% in patients without it,respectively(P<0.05). The incidence of adverse events postoperatively were not different among the treatment groups. Conclusion: Granisetron 40 mu g . kg(-1) given prior to anaesthesia reduces the incidence of PONV in patients with a history of PONV as well as in patients without it.
引用
收藏
页码:273 / 277
页数:5
相关论文
共 15 条
[1]  
ANDREWS P L R, 1992, European Journal of Cancer, V28A, pS2, DOI 10.1016/0959-8049(92)90628-F
[2]   THE ANTI-EMETIC POTENTIAL OF THE 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONIST BRL-43694 [J].
BERMUDEZ, J ;
BOYLE, EA ;
MINER, WD ;
SANGER, GJ .
BRITISH JOURNAL OF CANCER, 1988, 58 (05) :644-650
[3]  
BODNER M, 1991, ANESTH ANALG, V73, P250
[4]  
CARMICHAEL J, 1989, CANCER CHEMOTH PHARM, V24, P45
[5]   THE EFFECT OF ORAL ONDANSETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING AFTER MAJOR GYNECOLOGICAL SURGERY PERFORMED UNDER GENERAL-ANESTHESIA [J].
DUPEYRON, JP ;
CONSEILLER, C ;
LEVARLET, M ;
HEMMINGSEN, C ;
SCHOEFFLER, P ;
PEDERSEN, FM ;
GRIBOMONT, B ;
KAPLAN, LA .
ANAESTHESIA, 1993, 48 (03) :214-218
[6]   RETRACTED: Antiemetic effects of granisetron on postoperative nausea and vomiting in patients with and without motion sickness (Retracted article. See vol. 59, pg. 1171, 2012) [J].
Fujii, Y ;
Toyooka, H ;
Tanaka, H .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1996, 43 (02) :110-114
[7]   RETRACTED: OPTIMAL ANTIEMETIC DOSE OF GRANISETRON FOR PREVENTING POSTOPERATIVE NAUSEA AND VOMITING (Retracted article. See vol. 59, pg. 1178, 2012) [J].
FUJII, Y ;
TANAKA, H ;
TOYOOKA, H .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1994, 41 (09) :794-797
[8]   RETRACTED: REDUCTION OF POSTOPERATIVE NAUSEA AND VOMITING WITH GRANISETRON (Retracted article. See vol. 59, pg. 1180, 2012) [J].
FUJII, Y ;
TANAKA, H ;
TOYOOKA, H .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1994, 41 (04) :291-294
[9]  
FURUE H, 1990, J CLIN THERAPEUTIC M, V6, P49
[10]   EFFICACY OF ORALLY-ADMINISTERED ONDANSETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING - A DOSE RANGING STUDY [J].
KENNY, GNC ;
OATES, JDL ;
LEESER, J ;
ROWBOTHAM, DJ ;
LIP, H ;
RUST, M ;
SAUR, P ;
ONSRUD, M ;
HAIGH, CG .
BRITISH JOURNAL OF ANAESTHESIA, 1992, 68 (05) :466-470